Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boosted vs Unboosted Atazanavir in Naive HIV Patients
NCT00084253Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Jun 2004; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00084253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084253.